On Monday, October 06, 2025, Dalal Street witnessed a sharp rally in healthcare sector stocks. After the biggest CGHS rate revision in 15 years, leading hospital stocks like Apollo Hospitals, Fortis Healthcare, Narayana Hrudayalaya, Gland Pharma, and Global Health surged between 3% and 7%.
This move not only brings relief to the healthcare sector but also signals a potential opportunity for investors. So, let us understand the latest development in detail.
What’s Happening?
The government has announced yet another piece of good news for central government employees and pensioners. After the recent hike in Dearness Allowance (DA), major changes have now been made in the Central Government Health Scheme (CGHS), directly benefiting millions of beneficiaries.
On October 3, the government announced revisions to around 2,000 medical procedure rates, which will come into effect from October 13, 2025. The previous rates, implemented in 2014, had created payment-related challenges for both hospitals and employees.
The new rates are now determined based on hospital accreditation, city category, hospital type, and ward eligibility, making the pricing structure more transparent. Most importantly, cashless treatment will now become much easier. Since the package rates have been updated in line with actual costs, private hospitals will now be able to provide cashless services to CGHS cardholders without hesitation.
New CGHS Rate Structure
Hospitals not accredited by NABH/NABL will now receive 15% lower rates, while super-specialty hospitals will be entitled to 15% higher rates within the same city category.
Based on city classification, tier-II (Y) cities will have 10% lower rates, and tier-III (Z) cities will have 20% lower rates. In the North-Eastern states, Jammu & Kashmir, and Ladakh, tier-II rates will be applicable.
Additionally, the new rates have been set for semi-private wards, while general wards will have 5% lower rates and private wards will have 5% higher rates. Rates for consultation, radiotherapy, diagnostics, and day-care procedures will now remain uniform across all ward categories. However, for cancer surgeries, the old rules will continue to apply, whereas new rates will be applicable for chemotherapy, radiotherapy, and diagnostic procedures.
Impact on the Hospital Industry
It marks a significant positive step for the hospital industry. For a long time, CGHS patients had complained that private hospitals did not provide cashless treatment facilities, forcing them to make payments upfront and receive refunds months later. On the other hand, private hospitals argued that the old rates were insufficient to cover current medical costs.
With the new rate structure, the situation is expected to change substantially. According to the Financial Express, DAM Capital believes that if 10% of a hospital’s earnings come from government schemes and it maintains a 20% EBITDA margin, then with a 25% growth rate, revenue could rise by 2.5% and EBITDA by 10%.
What’s in it for Investors?
The revision could bring several key opportunities for investors as well. It is expected to contribute to the revenue growth of hospitals, especially those with higher exposure to government schemes. For instance, Yatharth Hospitals has a 35% exposure, Max Healthcare 21.8%, Narayana Health 18%, Global Health 18%, and Apollo Hospitals 9%. The new rates are likely to improve both the revenue growth and margins of these companies.
Following the announcement, the sector reacted positively. On Monday, October 06, 2025, shares of Max Healthcare rose by 3%, Yatharth Hospitals by 3.5%, and Apollo Hospitals by over 2%. Investors now expect that with higher earnings from government schemes, these hospitals’ profitability and cash flows could strengthen further.
What’s Next?
According to a senior official from the Ministry of Health, this reform had been long overdue, and the new rate structure is expected to restore trust between CGHS panel hospitals and beneficiaries. Officials clarified that hospitals must accept the new rates by October 13, failing which they will be removed from the CGHS list.
Analysts estimate that the CGHS rate revision could lead to an average reimbursement increase of 25-30%. Major institutions such as Fortis, Max Healthcare, and Apollo Hospitals are expected to benefit the most from this change. The new rates will likely encourage more private hospitals to join the scheme, making cashless treatment more accessible for patients.
*The companies mentioned in the article are for information purposes only. This is not investment advice.
*Disclaimer: Teji Mandi Disclaimer
